Department of Clinical Neurological Sciences, National Parkinson Foundation Centre of Excellence in Parkinson Disease and Movement Disorders Program, London Health Sciences Centre, Western University, London, ON, Canada
Mandar Jog
Affiliation:
Department of Clinical Neurological Sciences, National Parkinson Foundation Centre of Excellence in Parkinson Disease and Movement Disorders Program, London Health Sciences Centre, Western University, London, ON, Canada
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Montenegro-Garreaud, X, Hansen, AW, Khayat, MM, et al.Phenotypic expansion in KIF1A-related dominant disorders: A description of novel variants and review of published cases. Hum Mutat. 2020;41:2094–2104. DOI:10.1002/humu.24118.10.1002/humu.24118CrossRefGoogle ScholarPubMed
2
Pennings, M, Schouten, MI, Van Gaalen, J, et al.KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia. Eur J Hum Genet. 2020;28:40–49.10.1038/s41431-019-0497-zCrossRefGoogle ScholarPubMed
3
Vecchia, SD, Tessa, A, Dosi, C, et al.Monoallelic KIF1A-related disorders: A multicenter cross sectional study and systematic literature review. J Neurol. 2022;269:437–450. DOI:10.1007/s00415-021-10792-3.10.1007/s00415-021-10792-3CrossRefGoogle ScholarPubMed
4
Chiba, K, Takahashi, H, Chen, M, et al.Disease-associated mutations hyperactivate KIF1A motility and anterograde axonal transport of synaptic vesicle precursors. Proc Natl Acad Sci USA. 2019;116(37):18429–18434. DOI:10.1073/pnas.1905690116.10.1073/pnas.1905690116CrossRefGoogle ScholarPubMed
5
Richards, S, Aziz, N, Bale, S, et al.ACMG laboratory quality assurance committee. standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–424. DOI:10.1038/gim.2015.30.10.1038/gim.2015.30CrossRefGoogle Scholar
6
Cheon, CK, Lim, SH, Kim, YM, et al.Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene. Sci Rep. 2017;7:12527.10.1038/s41598-017-12999-9CrossRefGoogle ScholarPubMed
7
Klebe, S, Lossos, A, Azzedine, H, et al.KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: Distinct phenotypes according to the nature of the mutations. Eur J Hum Genet. 2012;20:645–649.10.1038/ejhg.2011.261CrossRefGoogle Scholar
8
Lee, JR, Srour, M, Kim, D, et al.De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy. Hum Mutat. 2015;36:69–78. DOI:10.1002/humu.22709.10.1002/humu.22709CrossRefGoogle ScholarPubMed